# MFAP5

## Overview
Microfibril-associated protein 5 (MFAP5) is a gene that encodes a matrix glycoprotein involved in the formation and maintenance of elastic fibers within the extracellular matrix (ECM). The protein, also known as microfibril-associated protein 5, plays a critical role in the structural integrity and elasticity of connective tissues by interacting with other microfibrillar components such as fibrillin-1. MFAP5 is involved in various cellular processes, including cell signaling, microfibril assembly, and elastinogenesis, and is particularly significant in the organization of the ECM (Li2018MFAP5; Barbier2014MFAP5). The protein's function extends to the regulation of endothelial cell behavior and angiogenesis, which are essential for vascular development and wound healing (Wu2019MFAP5). Additionally, MFAP5 has been implicated in cancer progression, where it interacts with signaling pathways that influence tumor growth and metastasis (Yeung2019Anticancer; Chen2019Stromal). Its involvement in these processes highlights its potential as a therapeutic target in various pathological conditions.

## Structure
MFAP5, or microfibril-associated protein 5, is a component of the extracellular matrix involved in the formation and maintenance of elastic fibers. The protein is encoded by the MFAP5 gene and is known to interact with fibrillin-1 and other microfibrillar components, playing a crucial role in the structural integrity of connective tissues (Barbier2014MFAP5). 

The primary structure of MFAP5 consists of a sequence of amino acids that form the protein's backbone. The secondary structure may include common motifs such as alpha helices and beta sheets, although specific details are not provided in the context. The tertiary structure refers to the overall three-dimensional shape of MFAP5, which is essential for its interaction with other proteins in the extracellular matrix, such as fibrillin-1, fibrillin-2, fibulin-1, and tropoelastin (Barbier2014MFAP5). 

MFAP5 undergoes post-translational modifications, including glycosylation, which can influence its function and interactions within the extracellular matrix (Zhu2020Molecular). The protein may exist in different splice variant isoforms, potentially affecting its role in various physiological and pathological processes (Zhu2020Molecular). These structural features and modifications are critical for MFAP5's function in maintaining the structural integrity of connective tissues.

## Function
MFAP5 (microfibril associated protein 5) is a matrix glycoprotein involved in the formation and maintenance of elastic fibers within the extracellular matrix (ECM). It plays a crucial role in cell signaling, microfibril assembly, and elastinogenesis, contributing to the structural integrity and elasticity of connective tissues (Li2018MFAP5). MFAP5 is active in various cellular processes, including cell adhesion and survival, and is particularly significant in the organization of the ECM (Han2023Microfibrilassociated).

In healthy human cells, MFAP5 is involved in the regulation of endothelial cell behavior and angiogenesis, which are essential for vascular development and wound healing (Wu2019MFAP5; Han2023Microfibrilassociated). During wound healing, MFAP5 promotes collagen deposition and angiogenesis, processes critical for tissue repair and regeneration (Han2023Microfibrilassociated). It is upregulated in specific fibroblast subpopulations that are involved in ECM organization, indicating its role in ECM synthesis and maintenance (Han2023Microfibrilassociated).

MFAP5's involvement in these molecular processes underscores its importance in maintaining tissue homeostasis and facilitating repair mechanisms, highlighting its potential as a therapeutic target in conditions where these processes are dysregulated.

## Clinical Significance
Mutations and altered expression of the MFAP5 gene have significant clinical implications in various diseases. In familial thoracic aortic aneurysms and dissections (TAAD), loss-of-function mutations in MFAP5 disrupt the extracellular matrix (ECM) organization, leading to aortic dilation. These mutations are associated with upregulation of the TGF-b/BMP signaling pathway, a hallmark of TAAD (Barbier2014MFAP5). 

In cancer, MFAP5 overexpression is linked to increased tumor aggressiveness and poor prognosis. In head and neck squamous cell carcinoma (HNSCC), MFAP5 promotes metastasis by activating the epithelial-mesenchymal transition (EMT) program through the AKT signaling pathway, correlating with advanced disease stages and poor patient outcomes (Xu2020Hypoxiainduced). In ovarian cancer, MFAP5 derived from cancer-associated fibroblasts enhances cancer cell motility and invasion, contributing to shorter overall survival (Leung2014Calciumdependent; Kujawa2022Microfibril). 

In intrahepatic cholangiocarcinoma (ICC), MFAP5 facilitates tumor growth and aggressiveness by activating the Notch1 signaling pathway, serving as a potential biomarker for diagnosis and prognosis (Li2019MFAP5). These findings underscore the role of MFAP5 in disease progression and its potential as a therapeutic target.

## Interactions
MFAP5, or microfibril associated protein 5, is involved in several interactions with other proteins that influence cancer progression. In bladder cancer, MFAP5 interacts with the NOTCH2 receptor, activating the NOTCH2/HEY1 signaling pathway. This interaction enhances the transcriptional activity of NOTCH2 by increasing the production of N2ICD through gamma-secretase cleavage (Zhou2020CAFs‐derived). MFAP5 also interacts with Reticulocalbin 2 (RCN2) in pancreatic cancer-associated fibroblasts, preventing its ubiquitination-mediated degradation. This interaction maintains RCN2 levels, which in turn activates the MAPK/ERK signaling pathway, leading to STAT1 phosphorylation and promoting hyaluronate synthesis (Duan2023Targeting).

In breast cancer, MFAP5 is secreted by cancer-associated fibroblasts and activates the Notch1 signaling pathway. This activation increases the expression of NICD1 and slug, key factors in the epithelial-mesenchymal transition (EMT), which is crucial for tumor progression (Chen2019Stromal). MFAP5's role in the tumor microenvironment is further highlighted by its interaction with αvβ3 integrin through its RGD binding motif, enhancing angiogenesis and metastasis via calcium-dependent signaling pathways (Yeung2019Anticancer). These interactions underscore MFAP5's significant role in modulating cancer cell behavior and the tumor microenvironment.


## References


[1. (Xu2020Hypoxiainduced) Qiaoshi Xu, Hanyue Chang, Xuerui Tian, Chao Lou, Hailong Ma, and Xi Yang. Hypoxia-induced mfap5 promotes tumor migration and invasion via akt pathway in head and neck squamous cell carcinoma. Journal of Cancer, 11(6):1596–1605, 2020. URL: http://dx.doi.org/10.7150/jca.38217, doi:10.7150/jca.38217. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.38217)

[2. (Yeung2019Anticancer) Tsz-Lun Yeung, Cecilia S. Leung, Kay-Pong Yip, Jianting Sheng, Long Vien, Laura C. Bover, Michael J. Birrer, Stephen T.C. Wong, and Samuel C. Mok. Anticancer immunotherapy by mfap5 blockade inhibits fibrosis and enhances chemosensitivity in ovarian and pancreatic cancer. Clinical Cancer Research, 25(21):6417–6428, November 2019. URL: http://dx.doi.org/10.1158/1078-0432.ccr-19-0187, doi:10.1158/1078-0432.ccr-19-0187. This article has 42 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.ccr-19-0187)

[3. (Kujawa2022Microfibril) Katarzyna Aleksandra Kujawa, Ewa Zembala-Nożynska, Joanna Patrycja Syrkis, Alexander Jorge Cortez, Jolanta Kupryjańczyk, and Katarzyna Marta Lisowska. Microfibril associated protein 5 (mfap5) is related to survival of ovarian cancer patients but not useful as a prognostic biomarker. International Journal of Molecular Sciences, 23(24):15994, December 2022. URL: http://dx.doi.org/10.3390/ijms232415994, doi:10.3390/ijms232415994. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms232415994)

[4. (Li2019MFAP5) Jian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, Chen-Song Huang, Xi-Tai Huang, Jie-Qin Wang, Zhuo-Xing Gao, Shi-Jin Li, Qiong-Cong Xu, Wei Zhao, and Xiao-Yu Yin. Mfap5 facilitates the aggressiveness of intrahepatic cholangiocarcinoma by activating the notch1 signaling pathway. Journal of Experimental &amp; Clinical Cancer Research, November 2019. URL: http://dx.doi.org/10.1186/s13046-019-1477-4, doi:10.1186/s13046-019-1477-4. This article has 16 citations.](https://doi.org/10.1186/s13046-019-1477-4)

[5. (Zhu2020Molecular) Sipin Zhu, Lin Ye, Samuel Bennett, Huazi Xu, Dengwei He, and Jiake Xu. Molecular structure and function of microfibrillar‐associated proteins in skeletal and metabolic disorders and cancers. Journal of Cellular Physiology, 236(1):41–48, June 2020. URL: http://dx.doi.org/10.1002/jcp.29893, doi:10.1002/jcp.29893. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.29893)

[6. (Leung2014Calciumdependent) Cecilia S. Leung, Tsz-Lun Yeung, Kay-Pong Yip, Sunila Pradeep, Lavanya Balasubramanian, Jinsong Liu, Kwong-Kwok Wong, Lingegowda S. Mangala, Guillermo N. Armaiz-Pena, Gabriel Lopez-Berestein, Anil K. Sood, Michael J. Birrer, and Samuel C. Mok. Calcium-dependent fak/creb/tnnc1 signalling mediates the effect of stromal mfap5 on ovarian cancer metastatic potential. Nature Communications, October 2014. URL: http://dx.doi.org/10.1038/ncomms6092, doi:10.1038/ncomms6092. This article has 94 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms6092)

[7. (Han2023Microfibrilassociated) Chen Han, Trevor R. Leonardo, Bruna Romana-Souza, Junhe Shi, Shalyn Keiser, Heidi Yuan, Mohamad Altakriti, Matthew J. Ranzer, Sammy Ferri-Borgogno, Samuel C. Mok, Timothy J. Koh, Seok Jong Hong, Lin Chen, and Luisa A. DiPietro. Microfibril-associated protein 5 and the regulation of skin scar formation. Scientific Reports, May 2023. URL: http://dx.doi.org/10.1038/s41598-023-35558-x, doi:10.1038/s41598-023-35558-x. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-35558-x)

[8. (Li2018MFAP5) Qingmei Li, Yanqin Zhang, and Qiuli Jiang. Mfap5 suppression inhibits migration/invasion, regulates cell cycle and induces apoptosis via promoting ros production in cervical cancer. Biochemical and Biophysical Research Communications, 507(1–4):51–58, December 2018. URL: http://dx.doi.org/10.1016/j.bbrc.2018.10.146, doi:10.1016/j.bbrc.2018.10.146. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2018.10.146)

[9. (Barbier2014MFAP5) Mathieu Barbier, Marie-Sylvie Gross, Mélodie Aubart, Nadine Hanna, Ketty Kessler, Dong-Chuan Guo, Laurent Tosolini, Benoit Ho-Tin-Noe, Ellen Regalado, Mathilde Varret, Marianne Abifadel, Olivier Milleron, Sylvie Odent, Sophie Dupuis-Girod, Laurence Faivre, Thomas Edouard, Yves Dulac, Tiffany Busa, Laurent Gouya, Dianna M. Milewicz, Guillaume Jondeau, and Catherine Boileau. Mfap5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. The American Journal of Human Genetics, 95(6):736–743, December 2014. URL: http://dx.doi.org/10.1016/j.ajhg.2014.10.018, doi:10.1016/j.ajhg.2014.10.018. This article has 104 citations.](https://doi.org/10.1016/j.ajhg.2014.10.018)

[10. (Duan2023Targeting) Yi Duan, Xiaozhen Zhang, Honggang Ying, Jian Xu, Hanshen Yang, Kang Sun, Lihong He, Muchun Li, Yongtao Ji, Tingbo Liang, and Xueli Bai. Targeting mfap5 in cancer-associated fibroblasts sensitizes pancreatic cancer to pd-l1-based immunochemotherapy via remodeling the matrix. Oncogene, 42(25):2061–2073, May 2023. URL: http://dx.doi.org/10.1038/s41388-023-02711-9, doi:10.1038/s41388-023-02711-9. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-023-02711-9)

[11. (Wu2019MFAP5) Yanmei Wu, Ping Wu, Quan Zhang, Wenjin Chen, Xishui Liu, and Weiqiang Zheng. Mfap5 promotes basal-like breast cancer progression by activating the emt program. Cell &amp; Bioscience, March 2019. URL: http://dx.doi.org/10.1186/s13578-019-0284-0, doi:10.1186/s13578-019-0284-0. This article has 25 citations.](https://doi.org/10.1186/s13578-019-0284-0)

[12. (Chen2019Stromal) Z. Chen, X. Yan, K. Li, Y. Ling, and H. Kang. Stromal fibroblast-derived mfap5 promotes the invasion and migration of breast cancer cells via notch1/slug signaling. Clinical and Translational Oncology, 22(4):522–531, June 2019. URL: http://dx.doi.org/10.1007/s12094-019-02156-1, doi:10.1007/s12094-019-02156-1. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12094-019-02156-1)

[13. (Zhou2020CAFs‐derived) Zheng Zhou, Di Cui, Meng‐Hao Sun, Jing‐Lang Huang, Zheng Deng, Bang‐Min Han, Xiao‐Wen Sun, Shu‐Jie Xia, Feng Sun, and Fei Shi. Cafs‐derived mfap5 promotes bladder cancer malignant behavior through notch2/hey1 signaling. The FASEB Journal, 34(6):7970–7988, April 2020. URL: http://dx.doi.org/10.1096/fj.201902659r, doi:10.1096/fj.201902659r. This article has 26 citations.](https://doi.org/10.1096/fj.201902659r)